Annual report
9220.TEDINET S100PETN
Period2021-04-01 → 2022-03-31
Filed2022-10-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amends S100OI1Z.
Key figures · 114
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥9.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥9.4bn | 2020-04-01 → 2021-03-31 | Cons. | Net sales |
| Revenue | ¥9.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥650m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Operating income | ¥528m | 2020-04-01 → 2021-03-31 | Cons. | Operating income |
| Ordinary income | ¥648m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥608m | 2020-04-01 → 2021-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥710m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥677m | 2020-04-01 → 2021-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥477m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥486m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥529m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Net income | ¥472m | 2020-04-01 → 2021-03-31 | Cons. | Profit loss |
| Total assets | ¥7.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥8.3bn | at 2021-03-31 | Cons. | Assets |
| Total assets | ¥8.0bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2022-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.8bn | at 2021-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31 | Cons. | Net assets |
| Net assets / equity | ¥632m | at 2020-03-31d | Cons. | Net assets |
| Cash and deposits | ¥1.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2021-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.7bn | at 2021-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥976m | at 2020-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥899m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥847m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥112m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥130m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥879m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥374m | 2020-04-01 → 2021-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥370m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥240.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥238.53 | 2020-04-01 → 2021-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥242.76 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥913.16 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥673.99 | at 2021-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥313.17 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 26.1% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.8% | at 2021-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 7.9% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 30.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 45.3% | 2020-04-01 → 2021-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 76.8% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 985 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 999 | at 2021-03-31 | Cons. | Number of employees |
| Employees | 1,051 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥8.8bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥8.1bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥7.6bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥7.1bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥6.1bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥581m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥470m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥578m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥546m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥581m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥420m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥172m | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥548m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥745m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥368m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥502m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥495m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥236m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥46m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥7.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥7.8bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥7.2bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.3bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥7.4bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.6bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.3bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.9bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.5bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥663m | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥688m | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥450m | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.7bn | at 2021-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥167.07 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.97 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥247.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1,180,342.28 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-228,316.14 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥860.61 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥694.69 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥331.59 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,441,562.86 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,249,658.08 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 25.2% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 9.4% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 6.0% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 21.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 45.8% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 73.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.5% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 2,200,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 2,200,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 200 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 938 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 888 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 840 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 785 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 729 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2021-04-01 → 2022-03-31 | ¥6m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥2.2bn |
| Nursing Care Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥59m |
| Nursing Care Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥282m |
| Nursing Care Businessreportable segment | employees | at 2022-03-31 | 643 pure |
| Nursing Care Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Nursing Care Businessreportable segment | segment assets | at 2022-03-31 | ¥4.3bn |
| Nursing Care Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥378m |
| Nursing Care Equipment Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥14m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥27m |
| Nursing Care Equipment Businessreportable segment | employees | at 2022-03-31 | 285 pure |
| Nursing Care Equipment Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2022-03-31 | ¥1.1bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥272m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥73m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥309m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥650m |
| Reconciling Itemsreconciling | capex | 2020-04-01 → 2021-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2020-04-01 → 2021-03-31 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-04-01 → 2021-03-31 | −¥1m |
| Reconciling Itemsreconciling | segment assets | at 2021-03-31 | ¥2.3bn |
| Nursing Care Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥227m |
| Nursing Care Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥303m |
| Nursing Care Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| Nursing Care Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥5.6bn |
| Nursing Care Businessreportable segment | segment assets | at 2021-03-31 | ¥4.9bn |
| Nursing Care Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥206m |
| Nursing Care Equipment Businessreportable segment | capex | 2020-04-01 → 2021-03-31 | ¥3m |
| Nursing Care Equipment Businessreportable segment | depreciation | 2020-04-01 → 2021-03-31 | ¥28m |
| Nursing Care Equipment Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| Nursing Care Equipment Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥3.8bn |
| Nursing Care Equipment Businessreportable segment | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1m |
| Nursing Care Equipment Businessreportable segment | segment assets | at 2021-03-31 | ¥1.1bn |
| Nursing Care Equipment Businessreportable segment | segment profit | 2020-04-01 → 2021-03-31 | ¥322m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-04-01 → 2021-03-31 | ¥230m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-04-01 → 2021-03-31 | ¥331m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-04-01 → 2021-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-04-01 → 2021-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-04-01 → 2021-03-31 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-03-31 | ¥6.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-04-01 → 2021-03-31 | ¥528m |
| Nursing Care Businessreportable segment | employees | at 2022-03-31 | 596 pure |
| Nursing Care Equipment Businessreportable segment | employees | at 2022-03-31 | 285 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,348
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments for transfer of business2 inv cf | Prior1YearDuration | － | JPY |
| Payments for transfer of business2 inv cf | CurrentYearDuration | -24985000 | JPY |
| Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YearDuration | － | JPY |
| Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYearDuration | -38242000 | JPY |
| Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YearDuration | 53619000 | JPY |
| Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYearDuration | － | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration | -111655000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration | -97012000 | JPY |
| Increase in short term loans payable fin cf | Prior1YearDuration | 1480000000 | JPY |
| Increase in short term loans payable fin cf | CurrentYearDuration | 1200000000 | JPY |
| Decrease in short term loans payable fin cf | Prior1YearDuration | -1779200000 | JPY |
| Decrease in short term loans payable fin cf | CurrentYearDuration | -1200000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration | 465000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration | 100000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration | -899461000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration | -582438000 | JPY |
| Repayments of installment payables fin cf | Prior1YearDuration | － | JPY |
| Repayments of installment payables fin cf | CurrentYearDuration | -116893000 | JPY |
| Repayments of lease obligations fin cf | Prior1YearDuration | － | JPY |
| Repayments of lease obligations fin cf | CurrentYearDuration | -29477000 | JPY |
| Redemption of bonds fin cf | Prior1YearDuration | － | JPY |
| Redemption of bonds fin cf | CurrentYearDuration | -250000000 | JPY |
| Proceeds from issuance of common stock fin cf | Prior1YearDuration | 360000000 | JPY |
| Proceeds from issuance of common stock fin cf | CurrentYearDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration | -373661000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration | -878808000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YearDuration | -195000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYearDuration | 16000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration | 695440000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration | -77215000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 976362000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1671802000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 1671802000 | JPY |
| Cash and cash equivalents | CurrentYearInstant | 1594586000 | JPY |
| Number of consolidated subsidiaries | CurrentYearInstant | 2 | |
| Number of associates accounted for using equity method | CurrentYearInstant | － | |
| Accumulated depreciation ppe by group | Prior1YearInstant | -2874965000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -2769845000 | JPY |
| Accumulated depreciation ppe by group | Prior1YearInstant | -2874965000 | JPY |
| Accumulated depreciation ppe by group | CurrentYearInstant | -2769845000 | JPY |
| Directors compensations sga | Prior1YearDuration | 113350000 | JPY |
| Directors compensations sga | CurrentYearDuration | 115250000 | JPY |
| Payroll and allowances sga | Prior1YearDuration | 236181000 | JPY |
| Payroll and allowances sga | CurrentYearDuration | 221453000 | JPY |
| Bonuses sga | Prior1YearDuration | － | JPY |
| Bonuses sga | CurrentYearDuration | 16356000 | JPY |
| Provision for bonuses sga | Prior1YearDuration | 34082000 | JPY |
| Provision for bonuses sga | CurrentYearDuration | 16665000 | JPY |
| Retirement benefit expenses sga | Prior1YearDuration | 5854000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration | 3561000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |